Abbott Laboratories operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other companies in this sector in UNITED STATES : Abbvie Inc (2019 sales of $33.27 billion of which 100% was Pharmaceutical Products), AstraZeneca PLC ($24.38 billion of which 100% was BioPharmaceuticals), and Bristol-Myers Squibb Company ($26.15 billion of which 30% was Prioritized Brands-Eliquis).

Sales Analysis. During the year ended December of 2019, sales at Abbott Laboratories were $31.90 billion. This is an increase of 4.3% versus 2018, when the company's sales were $30.58 billion. This was the fifth consecutive year of sales increases at Abbott Laboratories (and since 2014, sales have increased a total of 58%). Sales of Medical Devices saw an increase that was more than double the company's growth rate: sales were up 29.7% in 2019, from $9.44 billion to $12.24 billion. Not all segments of Abbott Laboratories experienced an increase in sales in 2019: sales of Other fell 97.1% to $57.00 million.